Unique ID issued by UMIN | UMIN000001508 |
---|---|
Receipt number | R000001717 |
Scientific Title | Osaka study of Nicorandil effect on Chronic Kidney Disease |
Date of disclosure of the study information | 2009/01/10 |
Last modified on | 2019/11/26 08:57:58 |
Osaka study of Nicorandil effect on Chronic Kidney Disease
ON-CKD study
Osaka study of Nicorandil effect on Chronic Kidney Disease
ON-CKD study
Japan |
Chronic kidney disease
Ischemic coronary disease
Cardiology | Nephrology |
Others
NO
To evaluate weather endothelial function of chronic kidney disease patients with risk factors for cardiovascular diseases could be improved by nicorandil.
Efficacy
Confirmatory
Pragmatic
Not applicable
Endothelial function measured by reactive hyperemia by pulse amplitude tonometry (RH-PAT) and augmentation index and cardiac stress marker.
The primary end point is death from all causes, morbidity and mortality from cardiovascular causes, a composite of myocardial infarction, stroke, first hospitalization for heart failure or unstable angina, coronary or peripheral
revascularization, or death from cardiovascular causes.
The time to the first event of
the composite end point of a doubling of the serum creatinine concentration, end-stage renal disease, or death is also set as a primary end point.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
YES
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
Nicorandil, 15mg/day, per os
No use of nicorandil
20 | years-old | <= |
Not applicable |
Male and Female
(1)Age, above 20 and below 75
(2)Chronic kidney disease.
(3)Patients with angina or silent myocardial ischemia
(4) Patients with endothelial dysfunction
(5) Patients who are obtained informed consent
(1)Liver cirrhosis
(2)Previous organ transplantation
(3)Administered anti-cancer drugs within 2 years
(4)Non Japanese
(5)Known HIV/AIDS
50
1st name | Yoshitaka |
Middle name | |
Last name | Isaka |
Osaka University School of Medicine
Department of Nephrology
567-0085
Box A8, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
06-6879-3632
y-isaka@kid.med.osaka-u.ac.jp
1st name | Yoshitaka |
Middle name | |
Last name | Isaka |
Osaka University Hospital
Department of Nephrology
567-0085
Box A8, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
06-6879-3632
y-isaka@kid.med.osaka-u.ac.jp
Osaka University School of Medicine
Department of Nephrology
Osaka University School of Medicine
Department of Nephrology
Self funding
Osaka University
2-15 Yamadaoka, Suita, Osaka
06-6979-5685
umezome@hp-crc.med.osaka-u.ac.jp
NO
2009 | Year | 01 | Month | 10 | Day |
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000001717
Unpublished
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000001717
19
Association with BNP reduction was observed.
2019 | Year | 11 | Month | 26 | Day |
Men and women aged at 20 to 75 who were being treated for advanced stages of CKD
Patients were recruited at the outpatient ward.
None observed.
The BNP concentration.
Completed
2009 | Year | 03 | Month | 01 | Day |
2008 | Year | 12 | Month | 01 | Day |
2009 | Year | 03 | Month | 01 | Day |
2014 | Year | 12 | Month | 01 | Day |
2014 | Year | 12 | Month | 01 | Day |
2015 | Year | 03 | Month | 01 | Day |
2015 | Year | 03 | Month | 01 | Day |
2008 | Year | 11 | Month | 15 | Day |
2019 | Year | 11 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001717